medical weight loss

The global e-pharmacy market reached a value of \$107.7 billion in 2024 and is expected to grow rapidly to \$324.67 billion by 2033, according to a recent report by IMARC…

Marshall County is experiencing significant progress in health technology with the establishment of ChatRx, an innovative medical technology company focused on AI-powered healthcare solutions. The company has chosen Plymouth as…

The New York State Department of Health (NYSDOH) has finalized a rule allowing the prescribing of controlled substances via telemedicine, setting exceptions to the usual requirement for in-person medical evaluations.…

An estimated 1.5 million people in the UK are currently using weight loss injections, and more could soon access these treatments through their general practitioners if they meet specific criteria.…

Eli Lilly and Company announced on Monday that it will lower the out-of-pocket cost for most doses of its weight-loss drug, Zepbound, for people who pay without insurance. Previously, prices…

The rising popularity of GLP-1 weight-loss drugs such as semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro), and liraglutide (Saxenda), along with other medications like Orlistat and Alli, is prompting urgent warnings…

Powerful new obesity drugs such as Wegovy and Zepbound are changing how the medical field approaches weight management and chronic disease. But beyond their clinical benefits, these drugs may be…

McDonald’s shares have declined by 1.7% following a downgrade from equity analysts at Redburn Atlantic, who cited the growing impact of popular weight loss drugs on consumer behavior. The shift,…

Eli Lilly has announced that starting July 7, 2025, the highest approved doses of its weight-loss drug Zepbound—12.5 mg and 15 mg—will be available in single-dose vials at a price…

A determined mother from West Lothian has transformed her life by losing four stones without using weight-loss drugs and is now preparing to inspire others as a newly trained Slimming…